Can-Fite Biopharma (CANF) Q2 2024 Earnings

30MayConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2024
-1.1
-0.73
-0.37
0

Details

Expected EPS
-0.001349
Actual EPS
-0.001166
Surprise EPS
0
Surprise Percent
+13.57%

Description

Can-Fite Biopharma (CANF) has reported earnings of -0.001166 per share for Q2 2024.

0 Comments

Share your thoughts